Los Angeles Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-5,488
| Closed | -$4.02M | – | 1454 |
|
2018
Q2 | $4.02M | Sell |
5,488
-375
| -6% | -$275K | 0.02% | 528 |
|
2018
Q1 | $9.35M | Buy |
5,863
+3,258
| +125% | +$5.19M | 0.05% | 330 |
|
2017
Q4 | $2.33M | Buy |
2,605
+1,782
| +217% | +$1.6M | 0.01% | 629 |
|
2017
Q3 | $296K | Buy |
+823
| New | +$296K | ﹤0.01% | 1153 |
|
2016
Q4 | – | Sell |
-742
| Closed | -$191K | – | 1212 |
|
2016
Q3 | $191K | Sell |
742
-261
| -26% | -$67.2K | ﹤0.01% | 1170 |
|
2016
Q2 | $214K | Buy |
+1,003
| New | +$214K | ﹤0.01% | 1141 |
|
2014
Q2 | – | Sell |
-1,388
| Closed | -$252K | – | 1260 |
|
2014
Q1 | $252K | Buy |
1,388
+664
| +92% | +$121K | ﹤0.01% | 1119 |
|
2013
Q4 | $123K | Sell |
724
-2,158
| -75% | -$367K | ﹤0.01% | 1246 |
|
2013
Q3 | $451K | Sell |
2,882
-50
| -2% | -$7.82K | 0.01% | 953 |
|
2013
Q2 | $508K | Buy |
+2,932
| New | +$508K | 0.01% | 904 |
|